FFPE
Biotium Acquires Nucleic Acid Extraction Technology From Cell Data Sciences
Biotium will become the sole manufacturer of Cell Data Sciences' RNAstorm and DNAstorm kits based on the CAT5 FFPE nucleic acid extraction technology.
The company is now seeking a partner to commercialize the technology for oncology in a kit format while it continues to grow its service business for the biopharmaceutical industry.
Startup OncXerna Therapeutics Explores Tumor Microenvironment to Help Guide Cancer Treatment
Premium
The Boston-based firm recently shared data indicating its RNA-seq panel can help guide colorectal cancer treatment with its in-licensed investigational drugs.
Biocept Nabs CE-IVD Mark, Makes EGFR Kits Available in Europe
The company said it can now market test kits for both liquid biopsy and FFPE samples to labs in the EU and other participating geographies.
The Stanford University spinout claims it can get three times the nucleic acid yield as column- or magnetic bead-based methods, with less damage to the molecules.